Plasma cell Dyscrasia 1- B.M.G. 2- Multiple Myeloma 3- Waldenstrom Macroglubolenemia 4- Heavy Chain disease 5- Amyloidosis.

Slides:



Advertisements
Similar presentations
Multiple Myeloma By Dr Sameh Shamaa. Multiple Myeloma Epidemiology: 1% Of all malignant diseases. Annual incidence: 3-4/ Age: - Median age: 65y.
Advertisements

Serum Electrophoresis AND IMMUNOFIXATION june 2013 Dr. Nitin A Inamdar Department of Biochemistry Tata Memorial Center
Tabuk University 1 3 rd Year – Level 5 – AY Faculty of Applied Medical Sciences Department Of Medical Lab. Technology.
Serum Protein Electrophoresis
PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Dr A. Mousavi.  15 % of all malignant white cell diseases  1% of all cancer deaths  Group of lymphoid neoplasms of terminally differentiated B-cells.
IMMUNITY.
CLS 404 Immunology Protein Abnormalities
Diagnosis of Paraprotein Diseases CLS 404 Immunology Protein Abnormalities.
Multiple Myeloma. Definition: Malignant proliferation of plasma cells derived from a single clone Etiology: radiation;mutations in oncogenes; familial.
Objectives To introduce the terminology used in describing the plasma cells neoplasm. To explain the physiology of the normal cells & the pathological.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Week 11: Lymphoproliferative Disorders Multiple myeloma Multiple myeloma Plasma cell Plasma cell Monoclonal gammopathy Monoclonal gammopathy Bence-Jones.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub- intern under Nephrology Division, Department of Medicine in King Saud University.
Waldenstrom’s Macroglobulinemia
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
MULTIPLE MYELOMA (MM).
Multiple Myeloma Alan Johns, M.D. Kristine Krafts, M.D.
Understanding Your Blood Work
Diagnostic Hematology: Disorders of Hemoglobin and Gammopathies Muhammad Shoaib Khan GM Centre - 1.
QUIZ OF THE WEEK By .. Shada AlGhamdi.
Director of Scientific Affairs
Multiple Myeloma Definition:
Clinical interpretation of Serum Free Light Chain assays 22 Feb 2013 Dr. Eric Chan Consultant Immunologist Queen Mary Hospital Hong Kong.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
IMMUNOCHEMISTRY PROFILES Dr. Thomas Williams. TESTS DISEASES CASES.
Multiple Myeloma Definition:
Plasma Cell Disorders Kristi McIntyre M.D. Texas Oncology 2004 Monoclonal Gammopathies.
Immunology Innate - Adaptive Immunity Specificity Memory Tolerance.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria MULTIPLE MYELOMA.
Epidemiology 12,000 deaths in United States per year
LYMPHOPROLIFERATIVE DISORDERS
Multiple Myeloma Morning Report July 21, 2009 Lindsay Kruska.
Justin A. Crocker.  1 of the monoclonal gammopathies  Neoplastic proliferation of immunoglobulin producing plasma cells (single clone), often resulting.
MLAB 1415: H EMATOLOGY K ERI B ROPHY -M ARTINEZ Chapter 26: Lymphoid Malignancies Part Two.
Biological functions transport –albumin –transferin –ceruloplasmin –haptoglobin oncotic pressure regulation coagulation immunity.
MLAB Hematology Keri Brophy-Martinez Lymphoid Malignancies.
C - reactive protein. C - reactive protein ( CRP ) ◌ C-reactive protein was originally discovered as a substance in the serum of patients with acute inflammation.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
Jesse C James MD AM Report May 7,  Proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein  Malignant.
Chicago Medical School
Dr Samal Nauhria .edu Plasma cell lesions Dr Samal Nauhria .edu.
 Serum protein electrophoresis is an easy method of separating serum proteins based on their net charge, size, and shape.  A small amount of serum is.
Paraproteinemic hemoblastoses – clonal malignancies in which the substratum is plasma cells on the stage of differentiation when they are already able.
Plasma Cell Dyscrasis Sanambar Sadighi Hematologist-Oncologist Cancer Institute.
Serum Protein Electrophoresis (SPEP)
M. Multiple Myeloma Malignant proliferation of plasma cells. Malignant proliferation of plasma cells. Normal plasma cell form Ig which contain heavy and.
R4 Jae Joon Han.
CONCEPT MAP CONCEPT MAP. 42 y/o male, CC: EDEMA ON BILATERAL EXTREMITIES. Diagnosed with a benign cystic lesion 8 yrs ago S/Sx: BONE PAINS, EASY FATIGUABILITY.
Case Study Multiple Myeloma.
Miten R. Patel, MD Cancer Specialists of North Florida
Para-proteinaemias dr.Mousa Qasim Hussein Assistant Professor
Paraproteinaemias. Multiple myeloma. Amyloidosis. Part 2 Dr
Prepared by : IBRAHEEM NIDAL ABU ATWAN SAEED YEHYA HAMMODA
Natural History and Treatment of Bone Complications in Prostate Cancer
MULTIPLE MYELOMA (MM) objective: definition of MM Biochemical investigation in Diagnosis.
MLAB Hematology Keri Brophy-Martinez
Dr WAQAR ASST. PROFESSOR INTERNAL MEDICINE
MLAB Hematology Fall 2007 Keri Brophy-Martinez
Section III Physiological Biochemistry Universities Press
A young patient with multiple myeloma
Multiple myeloma (MM) & related disorders
Natural History and Treatment of Bone Complications in Prostate Cancer
Parasternal mass Blood Volume 113(6): February 5, 2009
Multiple Myeloma and Understanding your Labs
PARAPRTEINAEMIA and MULTIPLE MYELOMA
Bence Jones protein The Bence Jones protein was described by the English physician Henry Bence Jones in 1847 and published in 1848.Henry Bence Jones The.
Presentation transcript:

Plasma cell Dyscrasia 1- B.M.G. 2- Multiple Myeloma 3- Waldenstrom Macroglubolenemia 4- Heavy Chain disease 5- Amyloidosis

Type of Monoclonal Paraproteins Percentage !gG ………………………… IgA …………………………………………… 21 IgD …………………………………………… 2 IgE ……………………………………………<0.01 L chains ( K or L) only ……………………. 11 H chain (G or A) only …………………….. <1 2 or more monoclonal paraproteins <1 No monoclonal paraprotein ………………. 1 IgM …………………………………………….. 12

Pathophysiological effects of paraproteins Raised serum globulin level Hypoalbuminemia Hyponatremia Dilutional anemia Raised ESR Rouleux formation in RBC Hyperviscosity Interference with Platelet function Interference with Coagulation pathway Proteinuria Renal failure Amyloidosis Cryoglobulinemia

Mechanisms of Bone diseas Development of osteolytic lesions appears to occur through at least two different mechanisms, via the production of various cytokines by myeloma cells adjacent to bone: - Stimulation of osteoclastic activity - Inhibition of osteoblastic activity

Adverse Prognostic factor in Multipla Myeloma Elevated B2 Microglobulin level High Plasma Cell Labeling index Elivated Lactate dehydrogenese Value Elevated Thymidine Kenase Value High C-reactive protein value Plasmablastic Morphology Hypoalbuminemia Advanced age Elevated Creatinine Concentration Hypodipoloidy, Low RNA content of Plasma cell Anemia,Thrombocytopenia,Hypercalcemia Primary resistance to therapy & progressive disease